• Pistoia Alliance Conference: exploring the importance of data to pharma

  Non-profit members' organisation The Pistoia Alliance held its European Conference in London in mid-March. Although...
  Read More...

• Novo Nordisk settles Victoza patent dispute with Teva in US

  Danish pharmaceutical company Novo Nordisk has reached an agreement with Teva Pharmaceuticals USA to settle...
  Read More...

• Allergy Therapeutics’ birch pollen product fails to meet primary endpoint

  UK-based Allergy Therapeutics has announced that its new adjuvanted allergoid product indicated for birch pollen-induced...
  Read More...

• Pharma industry venture financing deals in February 2019 total $1.7bn globally

  Total pharma industry venture financing deals in February 2019 worth $1.7bn were announced globally, according to GlobalData’s deals database. Embed…
  Read More…

• Pharma industry M&A deals in February 2019 total $28.83bn globally

  Total pharma industry M&A deals in February 2019 worth $28.83bn were announced globally, according to GlobalData’s deals database. Embed this…
  Read More…

• State of the European Union: too few API suppliers threaten supply chain

  A lack of capacity to produce sterile injectables is a big cause of drug shortages...
  Read More...

• M&A vs IPO: life science bankers say future of capital markets hazy for 2019

  Many bio/pharma IPOs in 2018 were of companies that had previously benefited from crossover investors.
  Read More...

• NASA calls for new vaccinations to combat virus reactivation during spaceflight

  Researchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight,...
  Read More...

• EC approves Roche’s MabThera for pemphigus vulgaris

  Swiss pharma giant Roche has announced that the European Commission (EC) has approved its drug...
  Read More...

• Where is the UK’s supply of Migraleve?

  Migraleve Pink pain relief tablets have been missing from pharmacy shelves in the UK, to...
  Read More...